Literature DB >> 3578280

The Hartnup phenotype: Mendelian transport disorder, multifactorial disease.

C R Scriver, B Mahon, H L Levy, C L Clow, T M Reade, J Kronick, B Lemieux, C Laberge.   

Abstract

The Hartnup mutation affects an amino acid transport system of intestine and kidney used by a large group of neutral charge alpha-amino acids (six essential and several nonessential). We compared developmental outcomes and medical histories of 21 Hartnup subjects, identified through newborn screening, with those of 19 control sibs. We found no significant differences in means of growth percentiles and IQ scores between Hartnup and control groups (but all low academic performance scores were found in the Hartnup group, and various skin lesions occurred in five Hartnup subjects), no significant difference between means of the summed plasma values for amino acids affected by the Hartnup gene in Hartnup and control groups, two Hartnup subjects with clinical manifestations--impaired somatic growth and IQ in one, impaired growth and a "pellagrin" episode in the other--who had the lowest summed plasma amino acid values in the Hartnup group; the corresponding values for their sibs were the low outliers in the control group, and two tissue-specific forms of the Hartnup (transport) phenotype: renal and intestinal involvement (15 families) and renal involvement alone (one family), both forms having been inherited as autosomal recessives (the symptomatic probands had the usual form). Whereas deficient activity of the "Hartnup" transport system is monogenic, the associated plasma amino acid value (measured genotype) is polygenic. The latter describes the parameter of homeostasis and liability to disease. Cause of Hartnup disease is multifactorial.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578280      PMCID: PMC1684147     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Stature and nutrition in cystinuria and Hartnup disease.

Authors:  J E COLLISS; A J LEVI; M D MILNE
Journal:  Br Med J       Date:  1963-03-02

2.  A study of the behaviour of some sixty amino-acids and other ninhydrin-reacting substances on phenol-;collidine' filter-paper chromatograms, with notes as to the occurrence of some of them in biological fluids.

Authors:  C E Dent
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

3.  Age at onset and causes of disease.

Authors:  B Childs; C R Scriver
Journal:  Perspect Biol Med       Date:  1986       Impact factor: 1.416

Review 4.  Genetic heterogeneity.

Authors:  B Childs; V M Der Kaloustian
Journal:  N Engl J Med       Date:  1968-11-28       Impact factor: 91.245

5.  Absorption of amino acids and peptides in a child with a variant of Hartnup disease and coexistent coeliac disease.

Authors:  M J Tarlow; J W Seakins; J K Lloyd; D M Matthews; B Cheng; A J Thomas
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

6.  Hartnup disorder in a New England family.

Authors:  J Pomeroy; M L Efron; J Dayman; D Hoefnagel
Journal:  N Engl J Med       Date:  1968-05-30       Impact factor: 91.245

7.  The molecular basis of dominance.

Authors:  H Kacser; J A Burns
Journal:  Genetics       Date:  1981 Mar-Apr       Impact factor: 4.562

8.  Effects of amino acid loads on a health infant with the biochemical features of Hartnup disease.

Authors:  J W Seakins; R S Ersser
Journal:  Arch Dis Child       Date:  1967-12       Impact factor: 3.791

9.  Natural history of Hartnup disease.

Authors:  B Wilcken; J S Yu; D A Brown
Journal:  Arch Dis Child       Date:  1977-01       Impact factor: 3.791

10.  Genetics and Medicine: an evolving relationship.

Authors:  C R Scriver; C Laberge; C L Clow; F C Fraser
Journal:  Science       Date:  1978-05-26       Impact factor: 47.728

View more
  17 in total

1.  Impaired nutrient signaling and body weight control in a Na+ neutral amino acid cotransporter (Slc6a19)-deficient mouse.

Authors:  Angelika Bröer; Torsten Juelich; Jessica M Vanslambrouck; Nadine Tietze; Peter S Solomon; Jeff Holst; Charles G Bailey; John E J Rasko; Stefan Bröer
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5.

Authors:  S J Potter; A Lu; B Wilcken; K Green; J E J Rasko
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

3.  Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. A clinico-pathological case study.

Authors:  K Schmidtke; W Endres; A Roscher; H Ibel; N Herschkowitz; C Bachmann; E Plöchl; H B Hadorn
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

Review 4.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

Review 5.  The salience of Garrod's 'molecular groupings' and 'Inborn Factors in Disease'.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.

Authors:  A J Jonas; I J Butler
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  A candidate mouse model for Hartnup disorder deficient in neutral amino acid transport.

Authors:  D J Symula; A Shedlovsky; E N Guillery; W F Dove
Journal:  Mamm Genome       Date:  1997-02       Impact factor: 2.957

Review 8.  Garrod's Croonian Lectures (1908) and the charter 'Inborn Errors of Metabolism': albinism, alkaptonuria, cystinuria, and pentosuria at age 100 in 2008.

Authors:  Charles R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-10-12       Impact factor: 4.982

9.  Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms.

Authors:  S E Waisbren; H L Levy; M Noble; D Matern; N Gregersen; K Pasley; D Marsden
Journal:  Mol Genet Metab       Date:  2008-08-03       Impact factor: 4.797

10.  Hartnup disease masked by kwashiorkor.

Authors:  Zerrin Orbak; Vildan Ertekin; Ayse Selimoglu; Nebahat Yilmaz; Huseyin Tan; Murat Konak
Journal:  J Health Popul Nutr       Date:  2010-08       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.